Compass Pathways PLC - American Depository Shares (CMPS) closed at $12.19 on October 29, 2026, down 0.7% from the previous close, on volume of 1,275,411 shares (30-day average 2,581,648).
Data as of October 29, 2026.
Business Wire (Wed, 28-Oct 6:30 AM ET)
Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026
Business Wire (Tue, 27-Oct 6:30 AM ET)
Business Wire (Wed, 14-Oct 6:30 AM ET)
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire (Fri, 2-Oct 6:30 AM ET)
Compass Pathways Appoints Kelley Boucher as Chief People Officer
Business Wire (Wed, 30-Sep 6:30 AM ET)
Business Wire (Wed, 16-Sep 6:30 AM ET)
Business Wire (Tue, 15-Sep 6:30 AM ET)
Business Wire (Fri, 11-Sep 4:10 PM ET)
Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training
PRNewswire (Thu, 10-Sep 8:01 AM ET)
Business Wire (Thu, 10-Sep 6:35 AM ET)
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.
As of October 29, 2026, CMPS stock price declined to $12.19 with 1,275,411 million shares trading.
CMPS has a beta of 2.41, meaning it tends to be more sensitive to market movements. CMPS has a correlation of 0.14 to the broad based SPY ETF.
CMPS has a market cap of $1.64 billion. This is considered a Small Cap stock.
In the last 3 years, CMPS traded as high as $15.87 and as low as $2.25.
The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, ORR, SBIO.
CMPS has outperformed the market in the last year with a price return of +86.1% while the SPY ETF gained +13.1%. CMPS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +12.4% and +8.2%, respectively, while the SPY returned +4.1% and 0.0%, respectively.
CMPS support price is $11.82 and resistance is $12.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.
